Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Papillomavirus Infections 11Warts 2Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2HIV Infections 2Condylomata Acuminata 2Acquired Immunodeficiency Syndrome 2Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Infections 1Human Papillomavirus-Related Cervical Carcinoma 1Human Papillomavirus-Related Carcinoma 1High Grade Anal Canal Intraepithelial Neoplasia 1Hematologic Neoplasms 1Cancer Survivor 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × High Grade Anal Canal Intraepithelial Neoplasia × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT03051516 2024-02-28

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Fred Hutchinson Cancer Center

Phase 4 Terminated
188 enrolled 13 charts
GastrointestinalGynecologic

High Grade Anal Canal Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡